Transitioned all 5 CTS labs from an investigational new drug (IND) to a licensed pooled Babesia test.
CTS embraces a company-wide operational excellence initiative designed to change the culture to enha...
As a component of the CTS Business Continuity Plan, today all 6 labs began using the same laboratory...
Continue to meet or exceed healthcare partners’ expectations by providing on-time test results appr...
By the end of 2017, CTS has secured three source plasma partners and continues to seek additional pa...
In January, CTS is incorporated as a non-profit organization owned by Vitalant and OneBlood (formerl...
In August, the CTS Tampa lab transitioned to the same laboratory information systems (LIS) as the Da...